+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiac Surgical Devices Market by Product Type, by Application, and by Age Group - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4612626
  • Report
  • Region: Global
  • 180 pages
  • Allied Analytics LLP
1 of 4
Cardiac surgery is the process performed to cure the heart tissue defects, for grafting, or for replacement of heart tissues in case of damage. There are two major types of heart surgeries-closed and open. Aging populations, elevating rates of obesity, poor nutrition, and health stressor majorly drive the market growth. In addition, rapid technological advancement, increase in awareness of the population, and demand for minimally invasive procedures also fuel the market growth. However, excessive cost of cardiac surgical devices and their maintenance is expected to restrain the growth of the market during the forecast period. The global cardiac surgical devices market is accounted for $1,700 million in 2016, and is estimated to reach $2,124 million by 2022, growing at a CAGR of 3.2% during the analysis period (2017-2023).

The market is segmented on the basis of product type, application, age-group, and geography. By product type, the market is categorized into beating heart surgery systems, cardiopulmonary bypass equipment, cardiac ablation devices, and perfusion disposable. Applications covered in the study include congenital heart defects, cardiac arrhythmia, coronary heart disease, congestive heart failure, and others. Based on age group, it is classified into new-born, infant, children, and adults. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS:

The study provides an in-depth analysis of the global cardiac surgical devices market, with current trends and future estimations to elucidate the investment pockets.
Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
The report provides a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of different segments facilitates to understand various products of the market.
Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.

Cardiac Surgical Devices Market Key Segments:

By Product Type

Beating Heart Surgery Systems
Cardiopulmonary Bypass Equipment
Cardiac Ablation Devices
Perfusion Disposables

By Application

Congenital Heart Defects
Cardiac Arrhythmia
Coronary Heart Disease
Congestive Heart Failure
Other Applications

By Age Group

New-born (0-30 days)
Infant (31 days-1 year)
Children (1-18 years)
Adult (18+ years)

By Geography

North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Others
Asia Pacific
Japan
China
India
Others
LAMEA
Latin America
Middle East
Africa

List of players profiled in the report

Edwards Life Science Corporation
Medtronic Inc.
Getinge Group
Atrion Corporation
Abbott Laboratories
Sorin S.P.A.
Terumo Medical Corporation
Boston Scientific Corporation
Cook Medical
Angiodynamics, Inc.

List of other players (These companies are not profiled in the report and same can be done on demand)

C. R. Bard, Inc.
Trinity Biotech
Abiomed, Inc.
Cardinal Health
CyberHeart Incorporated
MedWaves Incorporated
Transmedics, Inc.
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENT
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry
3.4. MARKET SHARE ANALYSIS, 2016
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Growing incidence of cardiac diseases
3.5.1.2. Large pool of geriatric population
3.5.1.3. Technological advancements
3.5.2. Restraints
3.5.2.1. High cost of cardiac surgery procedures
3.5.3. Opportunities
3.5.3.1. Lucrative opportunities in emerging economies

CHAPTER 4 CARDIAC SURGICAL DEVICES MARKET, BY PRODUCT TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. BEATING HEART SURGERY SYSTEMS
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.3. CARDIOPULMONARY BYPASS EQUIPMENT
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.4. CARDIAC ABLATION DEVICE
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.5. PERFUSION DISPOSABLE
4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast

CHAPTER 5 CARDIAC SURGICAL DEVICES MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. CONGENITAL HEART DEFECTS
5.2.1. Market size and forecast
5.3. CARDIAC ARRHYTHMIA
5.3.1. Market size and forecast
5.4. CORONARY HEART DISEASES
5.4.1. Market size and forecast
5.5. CONGESTIVE HEART FAILURE
5.5.1. Market size and forecast
5.6. OTHER APPLICATIONS
5.6.1. Market size and forecast

CHAPTER 6 CARDIAC SURGICAL DEVICES MARKET, BY AGE-GROUP
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. NEW-BORN POPULATION (0-30 DAYS)
6.2.1. Market size and forecast
6.3. INFANT POPULATION (31 DAYS-1 YEAR)
6.3.1. Market size and forecast
6.4. CHILDREN POPULATION (1-18 YEARS)
6.4.1. Market size and forecast
6.5. ADULT POPULATION (18+ YEARS)
6.5.1. Market size and forecast

CHAPTER 7 CARDIAC SURGICAL DEVICES MARKET, BY GEOGRAPHY
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S. market size and forecast
7.2.5. Canada market size and forecast
7.2.6. Mexico market size and forecast
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany market size and forecast
7.3.5. France market size and forecast
7.3.6. UK market size and forecast
7.3.7. Italy market size and forecast
7.3.8. Spain market size and forecast
7.3.9. Rest of Europe market size and forecast
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. China market size and forecast
7.4.5. Japan market size and forecast
7.4.6. India market size and forecast
7.4.7. Rest of Asia-Pacific market size and forecast
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Latin America market size and forecast
7.5.5. Middle East market size and forecast
7.5.6. Africa market size and forecast

CHAPTER 8 COMPANY PROFILES
8.1. ABBOTT LABORATORIES
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. ANGIODYNAMICS, INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. BOSTON SCIENTIFIC CORPORATION
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. COOK MEDICAL
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. EDWARDS LIFE SCIENCE CORPORATION
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. SORIN S.P.A.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. GETINGE GROUP
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. MEDTRONIC INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. ATRION CORPORATION
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. TERUMO MEDICAL CORPORATION
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Cardiac Surgical Devices Market Report, projects that the global market was valued at $1,700 million in 2016, and is projected to reach $2,124 million by 2023, growing at a CAGR of 3.2% from 2017 to 2023. The perfusion disposable segment held more than seven-tenths share of the total market in 2016.

Cardiac surgical devices are used for surgery performed to treat the complications of heart diseases such as valvar and congenital heart diseases. Constant technological developments, large pool of geriatric population, rise in incidence and prevalence of cardiac diseases, and increase in medical tourism in the developing countries are the factors that drive the growth of the market. However, high cost of the cardiac surgical procedures is projected to restrain the market growth during the forecast period.

Detailed segmentation of the global cardiac surgical devices market is provided in terms of product type, application, age-group, and geography. Based on product type, the market is divided into beating heart surgery systems, cardiopulmory bypass equipment, cardiac ablation devices, and perfusion disposables. The perfusion disposable market segment held the largest share in 2016 owing to high usage of perfusion disposables for keeping continuous heart beat and transferring oxygen to different parts of the body.

Based on application, the cardiac surgical devices market is segmented as congenital heart defects, cardiac arrhythmia, coronary heart disease, congestive heart failure, and other applications. Cardiac arrhythmia held the largest market share in 2016 owing to high prevalence of cardiac arrhythmia among adults as well as geriatric population.

Based on age-groups, the cardiac surgical devices market is segmented as new-born, infant, children, and adults. Adults undergo highest number of surgeries and hence captured the highest market share in 2016.

North America accounted for more than two fifths share in 2016, and is expected to domite the market throughout the forecast period. This is attributed to increase in incidence of cardiac diseases due to rise in geriatric population, well-established healthcare systems, and increase in awareness among the population toward timely diagnosis and treatment of cardiac diseases. In addition, higher adoption rate for technologically advanced devices is anticipated to provide new growth opportunities for the key players in the market. However, Asia-Pacific is projected to grow at the highest growth rate during the alysis period, owing to rise in healthcare expenditure, increase in per capita income, growth in demand for healthcare services from large pool of patient population, and improvement in healthcare infrastructure.

Key findings of the Cardiac Surgical Devices Market Study:

By product type, the perfusion disposable segment domited the market in 2016, and is projected to grow at the highest CAGR.
By application, the cardiac arrhythmia segment accounted for the highest share of in 2016.
The U.S. was the major shareholder in the North America cardiac surgical devices market in 2016.
Asia-Pacific is expected to show the highest growth rate during the alysis period.
Chi is expected to grow at the highest CAGR in the Asia-Pacific immunoprotein diagnostic testing market.

The major players profiled in the global cardiac surgical devices market are Edwards Life Science Corporation, Medtronic Inc., Getinge Group, Atrion Corporation, Abbott Laboratories, Sorin S.P.A., Terumo Medical Corporation, Boston Scientific Corporation, Cook Medical, and Angiodymics, Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4612626
Adroll
adroll